Regarding the role of glial cells in CNS oncogenesis, we and others have shown that dysregulated production of pro-inflammatory cytokines such as macrophage migration inhibitory factor (MIF) from glial cells and in the tumor microenvironment may contribute to the development, maintenance, and aggressiveness of GBM [12,13,14]. The gene discussed is MIF; the disease is glioblastoma.